We also tested a general γ-secretase inhibitor, DBZ, which is known to block Notch signaling and elicit strong effects on tumor and retina angiogenesis6, similarly to anti-Dll4 treatment (Extended Data Fig. 5g). This evidence concerns the gene ZNF365 and neoplasm.